These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 24493283)

  • 41. Increased disease activity is associated with altered sleep architecture in an experimental model of systemic lupus erythematosus.
    Palma BD; Tufik S
    Sleep; 2010 Sep; 33(9):1244-8. PubMed ID: 20857872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of glucan on murine lupus evolution and on host resistance to Klebsiella pneumoniae.
    Harima HA; Mendes NF; Mamizuka EM; Mariano M
    J Clin Lab Anal; 1997; 11(3):175-8. PubMed ID: 9138108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathogenicity of IgG-Fc desialylation and its association with Th17 cells in an animal model of systemic lupus erythematosus.
    Nishida Y; Shirakashi M; Hashii N; Nakashima R; Nakayama Y; Katsushima M; Watanabe R; Onizawa H; Hiwa R; Tsuji H; Kitagori K; Akizuki S; Onishi A; Murakami K; Yoshifuji H; Tanaka M; Tsuruyama T; Morinobu A; Hashimoto M
    Mod Rheumatol; 2024 Mar; 34(3):523-529. PubMed ID: 37300805
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bromocriptine treatment of systemic lupus erythematosus.
    Walker SE
    Lupus; 2001; 10(10):762-8. PubMed ID: 11721704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insulin resistance and obesity in a mouse model of systemic lupus erythematosus.
    Perciaccante A; Fiorentini A; Tubani L
    Hypertension; 2007 Feb; 49(2):e12; author reply e13. PubMed ID: 17159078
    [No Abstract]   [Full Text] [Related]  

  • 46. The role of diet in animal models of systemic lupus erythematosus: possible implications for human lupus.
    Corman LC
    Semin Arthritis Rheum; 1985 Aug; 15(1):61-9. PubMed ID: 3898377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Occupational and environmental exposures as risk factors for systemic lupus erythematosus.
    Cooper GS; Parks CG
    Curr Rheumatol Rep; 2004 Oct; 6(5):367-74. PubMed ID: 15355749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beta-glucan-indomethacin combination produces no lethal effects.
    Vetvicka V; Vetvickova J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Jun; 153(2):111-6. PubMed ID: 19771134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Experimental approach to the treatment of lupus nephritis by use of an accelerated model of the NZBxNZW mouse disease (author's transl)].
    Gayral-Ta Minh M; Lulé J; Fournié GJ; Mignon-Conté M; Pourrat JP; Haas S; Conté JJ
    Nephrologie; 1981; 2(3):102-6. PubMed ID: 7301029
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The interaction of innate immune and adaptive immune system.
    Wang R; Lan C; Benlagha K; Camara NOS; Miller H; Kubo M; Heegaard S; Lee P; Yang L; Forsman H; Li X; Zhai Z; Liu C
    MedComm (2020); 2024 Oct; 5(10):e714. PubMed ID: 39286776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced medullary and extramedullary granulopoiesis sustain the inflammatory response in lupus nephritis.
    Zervopoulou E; Grigoriou M; Doumas SA; Yiannakou D; Pavlidis P; Gasparoni G; Walter J; Filia A; Gakiopoulou H; Banos A; Mitroulis I; Boumpas DT
    Lupus Sci Med; 2024 Mar; 11(1):. PubMed ID: 38471723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trained Immunity Contribution to Autoimmune and Inflammatory Disorders.
    Funes SC; Rios M; Fernández-Fierro A; Di Genaro MS; Kalergis AM
    Front Immunol; 2022; 13():868343. PubMed ID: 35464438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. C-type lectin receptor Dectin3 deficiency balances the accumulation and function of FoxO1-mediated LOX-1
    Li D; Lu L; Kong W; Xia X; Pan Y; Li J; Wang J; Wang T; Liang J; Dou H; Hou Y
    Cell Death Dis; 2021 Sep; 12(9):829. PubMed ID: 34480018
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leaky-gut enhanced lupus progression in the Fc gamma receptor-IIb deficient and pristane-induced mouse models of lupus.
    Thim-Uam A; Surawut S; Issara-Amphorn J; Jaroonwitchawan T; Hiengrach P; Chatthanathon P; Wilantho A; Somboonna N; Palaga T; Pisitkun P; Leelahavanichkul A
    Sci Rep; 2020 Jan; 10(1):777. PubMed ID: 31964918
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kidney disease models: tools to identify mechanisms and potential therapeutic targets.
    Bao YW; Yuan Y; Chen JH; Lin WQ
    Zool Res; 2018 Mar; 39(2):72-86. PubMed ID: 29515089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan.
    Fagone P; Mangano K; Mammana S; Quattrocchi C; Magro G; Coco M; Imene S; Di Marco R; Nicoletti F
    Lupus; 2014 Apr; 23(4):407-11. PubMed ID: 24493283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner.
    Drake CG; Rozzo SJ; Hirschfeld HF; Smarnworawong NP; Palmer E; Kotzin BL
    J Immunol; 1995 Mar; 154(5):2441-7. PubMed ID: 7868910
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resistance to tolerance induction is not prerequisite to development of murine SLE.
    Izui S; Masuda K
    J Immunol; 1984 Dec; 133(6):3010-4. PubMed ID: 6491280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.